CLINICAL ROLE -
HIV, Chronic Kidney Disease Comorbidity Increases Risk of Serious Clinical Events
Patients with HIV who are diagnosed with chronic kidney disease have a higher burden of serious clinical events.
Read More
Trending News: Risk of Heart Failure Greater in Patients with Acute Myeloid Leukemia
Top news of the day from across the health care landscape.
Virus Characteristics Could Predict Efficacy of Antibody-Based Treatments in HIV
A study used sequence-based methods to identify specific virus characteristics that may help determine efficacy of antibody therapies in HIV.
Influenza Update: A look into the future of the “Universal” Flu Vaccine
Research has been conducted to produce a vaccination that gives patients long-lasting protection from influenza.
Perampanel Found to be Effective in Seizure Control in Patients with Partial-Onset Seizures
An analysis of efficacy and safety outcomes in patients receiving perampanel as first adjunctive antiepileptic drug found that almost half of the patients were seizure-free.
Lifestyle Behavior Change Can Prevent Progression of Chronic Kidney Disease
A recent study showed that effective lifestyle behavioral changes for patients with chronic kidney disease frequently involved education, goal setting, feedback, monitoring, and social support.
2019 Pharmacy Gift Guide
Jelly of the Month might not have impressed Clark Griswold, but we're sure there's a pharmacist on your gift list that would appreciate one of these items.
Practice Pearl 1: Understanding Misconceptions of Hepatitis C
Watch
Practice Pearl 1: Preventing Transmission With Syringe Exchange Programs
Practice Pearl 1: Hepatitis C Virus Transmission With Tattoos and Sex
Practice Pearl 1: Different Ways Hepatitis C Virus is Transmitted
Practice Pearl 1: Patient Education on Screening for Hepatitis C
Practice Pearl 1: Pregnancy and Annual Screening for Hepatitis C
Practice Pearl 1: Screening Recommendations for Hepatitis C
Complications of Hepatitis C: Hepatocellular Carcinoma
Complications of Hepatitis C: Cirrhosis and Decompensated Cirrhosis
Diagnosis of Hepatitis C
The Pathophysiology and Symptoms of Hepatitis C
Overview and Risk Factors of Hepatitis C
Best Practices for the Management of Hepatitis C
Anthrax Toxin: A Promising Method to Kill Bladder Cancer Cells
Researchers used an epidermal growth factor (EGF)-conjugated anthrax toxin that, after targeting EGFR, was internalized and triggered apoptosis in exposed bladder cancer cells.
Trending News: Home Hospital Model of Care Could Reduce Cost, Readmission
Cannabinoid Products May Lead to Cannabis-Positive Result in Urine Drug Tests
Approximately 2 out of 6 study participants tested positive after vaping cannabis that contained 0.39% THC using urine testing methods.
FDA Approves Enzalutamide for the Treatment of Metastatic Castration-Sensitive Prostate Cancer
With this approval, enzalutamide is the first and only oral treatment approved by the FDA in 3 distinct types of advanced prostate cancer.
CDC: Accelerated HIV Strategies Seek to Reach Goal of 90% Reduction by 2030
The CDC reported progress with the current status of the 3 strategies within the national initiative, Ending the HIV Epidemic: A Plan for America.
Study Compares 2-Dose Versus 3-Dose Hepatitis B Vaccine in Older Patients With Type 2 Diabetes
The immunogenicity and safety of hepatitis B surface antigen (HBsAg)/CpG 1018 was assessed in patients with diabetes aged 60 to 70 years.
SPS Associated with Higher Risk of GI Complications in Patients with Chronic Kidney Disease
A retrospective cohort study was the second largest evaluation to date of sodium polystyrene sulphonate use and safety in patients with chronic kidney disease.
Monday Pharmaceutical Mystery: December 16
What is causing a patient’s memory loss?
FDA Approves Icosapent Ethyl to Reduce Risk of Cardiovascular Event for Adults with Elevated Triglyceride Levels
Icosapent ethyl is the first FDA-approved prescription form of fish oil to reduce cardiovascular risk among patients with triglyceride levels as an add-on to maximally tolerated statin therapy.
FDA Approves Riluzole Supplemental New Drug Application for Adult Patients with Amyotrophic Lateral Sclerosis
The supplemental new drug application approval expands the patient population who stand to benefit from riluzole to include patients with ALS for whom swallowing is difficult and requires the use of percutaneous endoscopic gastrostomy feeding tube.
